Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon-γ release assay, and the development of active tuberculosis in HIV-seropositive persons

Diagnostic Microbiology and Infectious Disease

Volumn 69, Issue 1, 2011, Pages 59-65

  Santin, Miguel ^a,b,c   Casas, Susana ^a,b   Saumoy, Maria ^a   Andreu, Ana ^a   Moure, Raquel ^a   Alcaide, Fernando ^a,b,c   Ferrer, Elena ^a   Podzamczer, Daniel ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Department of Internal Medicine   (Spain)

Author keywords

HIV; IGRA; QuantiFERON TB Gold In Tube; Tuberculosis

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUBERCULIN TEST; WHOLE BLOOD INTERFERON GAMMA RELEASE ASSAY;

ADULT; BACTERIOLOGICAL TECHNIQUES; BLOOD; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; SENSITIVITY AND SPECIFICITY; SKIN; TUBERCULIN TEST;

EID: 78649930114     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.09.005     Document Type: Article

References (29)

1. Aaybe M.G., Ravn P., PrayGod G., Jeremiah K., Mugomela A., Jepsen M., Faurholt D., Range N., Friis H., Changalucha J., Andersen A.B. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS ONE 2009, 4:e4220.
2. Aichelburg M.C., Rieger A., Breitenecker F., Pfistershammer K., Tittes J., Eltz S., Aichelburg A.C., Stingl G., Makristathis A., Kohrgruber N. Detection and prediction of active tuberculosis disease by a whole-blood interferon-γ release assay in HIV-1-infected individuals. Clin. Infect. Dis. 2009, 48:954-962.
3. Alcaide J., Altet M.N., Canela-Soler J., Pina J.M., Milà C., de Souza M.L., Jiménez A., Solsona J., Ventosa J., Salleras L. A study of the tuberculous infection in adults. Rev. Clin. Esp. 2003, 203:321-328.
4. Alcaide J., Altet M.N., de Souza M.L., Jimenez M.A., Mila C., Solsona J. Active tuberculosis case finding among immigrants in Barcelona. Arch. Bronconeumol. 2004, 40:453-458.
5. Arend S., Thijsen S., Leyten E., Bouwman J., Franken W., Koster B., Cobelens F.J., van Houte A.J., Bossink A.W. Comparison of two interferon-g assays and tuberculin skin test for tracing tuberculosis contacts. Am. J. Respir. Crit. Care. Med. 2007, 175:618-627.
6. Brock I., Ruhwald M., Lundgren B., Westh H., Mathiesen L.R., Ravn P. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-γ test. Respir. Res. 2006, 7:56-64.
7. Bucher H.C., Griffith L.E., Guyatt G.H., Sudre P., Naef M., Sendi P., Battegay M. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS 1999, 13:501-507.
8. Cattamanchi A., Ssewenyana I., Davis J.C., Huang L., Worodria W., den Boon S., Samuel Y., Andama A., Hopewell P.C., Cao H. Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection. BMC Infect. Dis. 2010, 10:75.
9. Cobelens F.G., Egwaga S.M., van Ginkel T., Muwinge H., Matee M.I., Borgdorff M.W. Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values. Clin. Infect. Dis. 2006, 43:634-639.
10. Connell T.G., Curtis N., Ranganathan S.C., Buttery J.P. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 2006, 61:616-620.
11. Ferrara G., Losi M., Meacci M., Meccugni B., Piro R., Roversi P., Bergamini B.M., D'Amico R., Marchegiano P., Rumpianesi F., Fabbri L.M., Richeldi L. Routine hospital use of a new commercial whole blood interferon-γ assay for the diagnosis of tuberculosis infection. Am. J. Respir. Crit. Care Med. 2005, 172:631-635.
12. Girardi E., Antonucci G., Vanacore P., Palmieri F., Matteelli A., Iemoli E., Carradori S., Salassa B., Pasticci M.B., Raviglione M.C., Ippolito G. Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy. Eur. Respir. J. 2004, 24:11-17. GISTA-SIMIT Study Group, and the GISTA-SIMIT Study Group and the GISTA-SIMIT Study Groupand the GISTA-SIMIT Study Group and the GISTA-SIMIT Study Group.
13. Gordin F.M., Matts J.P., Miller C., Brown L.S., Hafner R., John S.L., Klein M., Vaughn A., Besch C.L., Perez G., Szabo S., El-Sadr W. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. N. Engl. J. Med. 1997, 337:315-320.
14. Guelar A., Gatell J.M., Verdejo J., Podzamczer D., Lozano L., Aznar E., Jm M.i.r.o., Mallolas J., Zamora L., Gonzalez J., Soriano E. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 1993, 7:1345-1349.
15. Jones S., de Gijsel D., Wallach F.R., Gurtman A.C., Shi Q., Sacks H. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int. J. Tuberc. Lung Dis. 2007, 11:1190-1995.
16. Kabeer B.S.A., Sikhamani R., Swaminathan S., Perumal V., Paramasivam P., Raja A. Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals. PLoS ONE 2009, 4:e5718.
17. Kaplan J.E., Benson C., Holmes K.K., Brooks J.T., Pau A., Masur H. Guidelines for preventing opportunistic infections among HIV-infected adults and adolescents. Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Early Release 2009, 58:1-58.
18. Karam F., Mbow F., Fletcher H., Senghor C.S., Coulibaly K.D., LeFevre A.M., NgoM Gueye N.F., Dieye T., Sow P.S., Mboup S., Lienhardt T. Sensitivity of IFN-γ release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS ONE 2008, e1441:3.
19. Luetkemeyer A.F., Charlebois E.D., Flores L.L., Bangsberg D.R., Deeks S.J., Martin J.N., Havlir D.W. Comparison of an interferon-γ release assay with tuberculin skin testing in HIV-infected individuals. Am. J. Respir. Crit. Care Med. 2007, 175:737-742.
20. Markowitz N., Hansen N.I., Wilcosky T.C., Hopewell P.C., Glassroth J., Kvale P.A., Mangura B.T., Osmond D., Wallace J.M., Rosen M.J., Reichman L.B. Tuberculin and anergy testing in HIV seropositive and HIV seronegative persons. Pulmonary complications of HIV infection study group. Ann. Intern. Med. 1993, 119:185-193.
21. Moreno S., Baraia-Etxaburu J., Bouza E., Parras F., Pérez-Tascón M., Miralles P., Vicente T., Alberdi J.C., Cosin J., Lopez-Gay D. Risk for developing tuberculosis among anergic patients infected with HIV. Ann. Intern. Med. 1993, 119:194-198.
22. Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 2008, 149:177-184.
23. Pape J.W., Jean S.S., Ho J.L., Hafner A., Johnson W.D. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993, 342:268-272.
24. Raby E., Moyo M., Devendra A., Banda J., De Haas P., Ayles H., Godfrey-Faussett P. The effects of HIV on the sensitivity of a whole blood IFN-γ release assay in Zambian adults with active tuberculosis. PLoS ONE 2008, 6:e2489.
25. Rangaka M.X., Wilkinson K.A., Seldon R., Van Cutsem G., Meintjes G.A., Morroni C., Mouton P., Diwakar L., Connell T.G., Maartens G., Wilkinson R.J. Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am. J. Respir. Crit. Care Med. 2007, 175:514-520.
26. Richeldi L., Losi M., D'Amico R., Luppi M., Ferrari A., Mussini C., Codeluppi M., Cocchi S., Prati F., Paci V., Meacci M., Meccugni B., Rumpianesi F., Roversi P., Cerri S., Luppi F., Ferrara G., Latorre I., Gerunda G.E., Torelli G., Esposito R., Fabbri L.M. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 2009, 136:198-204.
27. Stephan C., Wolf T., Goetsch U., Bellinger O., Nisius G., Oremek G., Rakus Z., Gottschalk R., Stark S., Brodt H.R., Staszewski S. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 2008, 22:2471-2479.
28. Talati N.J., Seybold U., Humphrey B., Aina A., Tapia J., Weinfurter P., Albalak R., Blumberg H.M. Poor concordance between interferon-γ release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect. Dis. 2009, 9:15.
29. Thijsen S.F.T., Bossink W.J. Interferon gamma release assays for diagnosing active and latent tuberculosis. Exp. Opin. Med. Diagn. 2009, 3:303-312.